跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet - TGA Drug Approval Details
Approvals
/
TGA
/
B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet
Approved
STANDARD
B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet
AU Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0403c1cd81fdfc3e
Company
AU Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
0403c1cd81fdfc3e
Product Name
B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet
Artg Id
398557
Artg Name
B-PATCH buprenorphine 30 microgram/hour transdermal drug delivery system sachet
Sponsor
AU Pharma Pty Ltd
Artg Date
2023-11-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02115-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01618-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0403c1cd81fdfc3e
Type
Standard
Back to TGA Approvals